Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/28/2016
Monvida Licenses China and Vietnam Rights of TumorSelect Paclitaxel fr...
8/26/2016
Lee's Pharma and Beijing Shenogen Agree to Co-develop Compound Antican...
8/26/2016
Roche Announces Price Reduction for Anticancer Tarceva in China
8/26/2016
Anhui Introduces New Policy to Prefer Local Drugs in Public Hospital P...
8/26/2016
NDRC Issues Notice to Advance Medical Service Price Reform
8/26/2016
State Council TCM Inter-ministerial Conference Established
8/26/2016
Eight Government Agencies Issue Notice for Urban and Rural Resident Cr...
8/26/2016
14 Government Agencies Introduce National Action Plan for Bacteria Res...
8/26/2016
CFDA Solicits Comments for Announcement over Drug Clinical Trial Inspe...
8/25/2016
Sinohealth: Chinese Pharma Growth Expected to Slow Further in 2016
8/25/2016
CFDA Terminates Import of LLM’s Difrarel Tablets for Unreported Plant...
8/25/2016
Recent Executive Moves
8/25/2016
21 Chinese Hospitals to Adopt Watson for Oncology for Cancer Care
8/25/2016
China to Grow Big on e-Healthcare Data
8/25/2016
BioLineRx, Chinese VC Form Pharma R&D JV in China
8/25/2016
China's BGI Invests in Australian Genomics R&D
8/25/2016
Anhui Model: Will It Be the Future of China's Health Care Provider Pay...
8/25/2016
Chinese Leadership Highlights the Way Forward for Healthcare
8/25/2016
Asia's Pharma Investment Shows the Benefit of Patent Protection
8/25/2016
Former Chinese Pharma Executive Settles China Charges for US$30M
8/25/2016
Building A Better Government Affairs Function In China
8/25/2016
China's New Regulation on Health Care and Medical Big Data Might Unloc...
8/19/2016
Luye Medical Enters Strategic Alliance MOU with Chongqing Municipal Go...
8/19/2016
Histogen Receives $6 Mln Investment From Huapont for Hair Growth Produ...
8/19/2016
Upcoming Event: Pharma Business Development Course
8/19/2016
CFDA Seeks Comments on GLP Amendment
8/19/2016
SMEI: Chinese Urban and County Level Public Hospital Drug Markets Up 9...
8/19/2016
SMEI: Chinese Online Pharmacy Drug Sales Up 52.4% in 2015
8/18/2016
BeiGene Approved for Clinical Trials in China with PARP Inhibitor BGB-...
8/18/2016
CFDA Issues Dossier Requirements for Quality and Efficacy Equivalence ...
Page:
336
/
720
Total number of articles:
21594
:
[First]
[<<]
[334]
[335]
[336]
[337]
[338]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit